Provexis Revenue

Provexis had revenue of 364.37K GBP in the half year ending September 30, 2025, a decrease of -5.98%. This brings the company's revenue in the last twelve months to 871.27K, down -27.38% year-over-year. In the fiscal year ending March 31, 2025, Provexis had annual revenue of 1.29M with 61.13% growth.

Revenue (ttm)

871.27K

Revenue Growth

-27.38%

P/S Ratio

30.83

Revenue / Employee

435.63K

Employees

Market Cap

26.86M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.29M	490.28K	61.13%
Mar 31, 2024	801.96K	412.05K	105.68%
Mar 31, 2023	389.92K	-36.25K	-8.51%
Mar 31, 2022	426.17K	-79.16K	-15.67%
Mar 31, 2021	505.33K	157.39K	45.24%
Mar 31, 2020	347.94K	25.75K	7.99%
Mar 31, 2019	322.19K	86.39K	36.63%
Mar 31, 2018	235.80K	8.19K	3.60%
Mar 31, 2017	227.62K	135.97K	148.36%
Mar 31, 2016	91.65K	53.43K	139.77%
Mar 31, 2015	38.22K	34.26K	863.55%
Mar 31, 2014	3.97K	-33.38K	-89.38%
Mar 31, 2013	37.35K	-3.44M	-98.93%
Mar 31, 2012	3.48M	3.43M	6,843.78%
Mar 31, 2011	50.09K	-44.68K	-47.15%
Mar 31, 2010	94.77K	69.37K	273.10%
Mar 31, 2009	25.40K	-269.95K	-91.40%
Mar 31, 2008	295.35K	183.71K	164.56%
Mar 31, 2007	111.64K	-423.68K	-79.15%
Mar 31, 2006	535.32K	-682.01K	-56.03%
Mar 31, 2005	1.22M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Haleon	11.15B
Hikma Pharmaceuticals	2.49B
HUTCHMED (China)	413.87M
Animalcare Group	89.11M
ECO Animal Health Group	87.53M
Allergy Therapeutics	57.29M
Shield Therapeutics	36.93M
Venture Life Group	35.17M

Revenue Rankings

Provexis News

5 weeks ago - AIM Market Roundup: Ramsdens, Provexis, Pulsar Helium - The Armchair Trader
9 months ago - AIM Market Roundup: Provexis, Geo Exploration, Sabien - The Armchair Trader

More News